You may be asking “how worried do I need to be about this Zantac recall”? The FDA released a notice outlining a concern for a probable carcinogenic chemical found in ranitidine and other similar heartburn medications. There have been manufacturer recalls, patients are switching their medications, and the FDA is currently investigating. We are joined by two VillageMD experts, Prasanga Lokuge and Saba Syed, to walk us through what is happening, what you need to tell your patients, and what to think about when changing medications.
To listen to this weeks episode, click here.